Drugs / GHB01L1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00724997 | Mar 2007 → Jul 2008 | influenza | AVIR Green Hills Biotechnology AG | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GHB01L1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00724997 ↗ |
| Known as | DeltaNS1-H1N1 | “Healthy seronegative adult volunteers were randomized to receive either a single intranasal dose of the DeltaNS1-H1N1 A/New Caledonia vaccine at 1 of 5 dose levels (6.4, 6.7,...” PMID 20039806 ↗ Feb 2010 |
| Modality | Vaccine | “monovalent replication-deficient delNS1-H1N1 influenza virus vaccine” PMID 24560674 ↗ Feb 2014 |
| Route | Intranasal | “administered as single dose intranasal aerosol” NCT00724997 ↗ |